We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
-16.49%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$157M
AUM Growth
+$8.15M
Cap. Flow
+$33.8M
Cap. Flow %
21.48%
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$26.2M
2
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
+$7.7M

Top Sells

Rank Stock Value
1
HALL
Hallmark Financial Services, Inc.
HALL
+$75.3K

Sector Composition

Rank Sector Weight
1 Healthcare 95.29%
2 Financials 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDGL icon
1
Madrigal Pharmaceuticals
MDGL
$12.6B
$150M 95.29%
818,339
+143,072
+21% +$26.2M
CPXX
2
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
$7.3M 4.64%
+2,246,469
New +$7.7M
HALL
3
DELISTED
Hallmark Financial Services, Inc.
HALL
$119K 0.08%
1,345
-848
-39% -$75.3K

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
EAMS
Eurizon Asset Management Slovakia Bratislava $3.4M AUM
RCP
RPM Capital Partners New York $3.34M AUM 43.17% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return

Caxton Corporation's Q4 2013 Portfolio in Review

As of Q4 2013, Caxton Corporation held 3 positions worth $157M, up 5.5% from $149M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Caxton Corporation deployed $33.8M of net new capital in Q4 2013, opening 1 new position and adding to 1 existing holding. Its largest new stake was CELATOR PHARMACEUTICALS INC. COMMON STOCK: 2,246,469 shares worth $7.3M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 100% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Hallmark Financial Services, Inc., an estimated $75.3K trimmed.

  • Caxton Corporation's largest Q4 2013 buy was CELATOR PHARMACEUTICALS INC. COMMON STOCK: 2,246,469 shares worth $7.3M.
  • Caxton Corporation added most to Madrigal Pharmaceuticals in Q4 2013, an estimated $26.2M increase.
  • Caxton Corporation's biggest Q4 2013 reduction was Hallmark Financial Services, Inc., cutting an estimated $75.3K.
  • Caxton Corporation's ten largest holdings make up 100% of its $157M portfolio in Q4 2013.
  • Caxton Corporation opened 1 new position and closed 0 in Q4 2013.
  • Caxton Corporation's portfolio value rose 5.5% quarter-over-quarter to $157M.

Based on Caxton Corporation's 13F filing for Q4 2013, filed 14 Feb 2014.